CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $34,252
- in 1 filing
Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-05-07 | Evans James S Chief Financial Officer | Exercise or conversion | +8,750 | $4.44 | $39K | 43,041 |
| 2010-05-07 | Evans James S Chief Financial Officer | Exercise or conversion · Incentive Stock Option (right to buy) | −8,750 | 0 | ||
| 2010-05-07 | MELDRUM PETER D President & C.E.O. | Exercise or conversion | +8,196 | $8.63 | $71K | 210,025 |
| 2010-05-07 | MELDRUM PETER D President & C.E.O. | Exercise or conversion · Incentive Stock Option (right to buy) | −8,196 | 0 | ||
| 2010-03-03 | Harrison Robert Gardner Chief Information Officer | Grant or award · Incentive Stock Option (right to buy) | +4,328 | 4,328 | ||
| 2010-03-03 | Harrison Robert Gardner Chief Information Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +30,672 | 30,672 | ||
| 2010-03-03 | LANCHBURY JERRY S Chief Scientific Officer | Grant or award · Incentive Stock Option (right to buy) | +4,328 | 4,328 | ||
| 2010-03-03 | LANCHBURY JERRY S Chief Scientific Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +50,672 | 50,672 | ||
| 2010-02-18 | Capone Mark Christopher Chief Operating Officer, MGL | Exercise or conversion | +5,000 | $7.27 | $36K | 40,454 |
| 2010-02-18 | Capone Mark Christopher Chief Operating Officer, MGL | Exercise or conversion | +2,000 | $8.63 | $17K | 42,454 |
| 2010-02-18 | Capone Mark Christopher Chief Operating Officer, MGL | Exercise or conversion · Incentive Stock Option (right to buy) | −5,000 | 20,000 | ||
| 2010-02-18 | Capone Mark Christopher Chief Operating Officer, MGL | Exercise or conversion · Incentive Stock Option (right to buy) | −2,000 | 10,000 | ||
| 2008-03-20 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion | +400 | $9.31 | $4K | 252,965 |
| 2008-03-20 | SKOLNICK MARK H Chief Scientific Officer | Sale | −400 | $34.91 | $14K | 252,565 |
| 2008-03-20 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion | +1,600 | $9.31 | $15K | 254,165 |
| 2008-03-20 | SKOLNICK MARK H Chief Scientific Officer | Sale | −1,600 | $34.90 | $56K | 252,565 |
| 2008-03-20 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −100 | 19,900 | ||
| 2008-03-20 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −100 | 19,800 | ||
| 2008-03-20 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −200 | 19,600 | ||
| 2008-03-20 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −500 | 19,100 |
Page 54 of 60 · 1,194 trades